ArticleMolecular psychiatry2026
MAPT-derived circTau6 induces tau pathogenesis and neurodegeneration by encoding Tau variants.
Article in Molecular psychiatry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
20 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Imbalanced accumulation of microtubule-associated protein tau containing three or four repeat domains (3 R or 4 R tau) is a core feature of tauopathies, which may result from alternative splicing of the MAPT mRNA. However, specific mechanisms yielding the imbalance were underinvestigated. Here, we identify a circular RNA (circTau6) derived from the MAPT gene in the human brain. CircTau6 was rolling-translated into novel 4 R tau variants, cTau4R. The cTau4R proteins were intrinsically hyperphosphorylated and promoted phosphorylation and aggregation of naive tau proteins derived from linear MAPT mRNA. Upregulation of cTau4R led to deposition of 4 R and phosphorylated tau forms in human MAPT knock-in mice (hMAPT mice), accompanied by neuronal and synaptic damage, neuroinflammation, and cognitive deficits. Further, CircTau6 overexpression partially recapitulated molecular signatures observed in human tauopathic brains, and its expression was directly regulated by tauopathy-associated MAPT mutations. These findings identify circTau6/cTau4R as a post-transcriptional mechanism that modulates tauopathy.
Identifiers
42477443What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.